文献速递其他结缔组织病

特发性炎症性肌病患者的自身抗体与损伤:MYONET国际网络的纵向多中心研究

Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network.
PubMed 文献 · Semin Arthritis Rheum · 2024-08-08

基于MYONET注册库757例成人特发性炎症性肌病患者,按肌炎特异性、肌炎相关性或血清阴性自身抗体分组,用线性混合模型分析损伤指数纵向轨迹。血清阴性组每病程年MDI评分增加0.16分;与血清阴性组相比,皮肌炎特异性抗体组每随访年评分少增加0.08分(P=0.04),抗PM/Scl抗体组每随访年多增加0.28分(P=0.03)。

要点

  • 血清阴性组每病程年MDI评分增加0.16分(参照组)。
  • 皮肌炎特异性抗体组较血清阴性组每随访年MDI少增加0.08分(P=0.04)。
  • 抗PM/Scl抗体组较血清阴性组每随访年MDI多增加0.28分(P=0.03)。

核心结论

  • 本研究首次在大型国际多中心特发性炎症性肌病队列中描述按自身抗体定义亚组的损伤随时间变化模式和轨迹。
  • 抗PM/Scl抗体患者损伤程度更高,而皮肌炎特异性抗体患者损伤低于血清阴性患者。
  • 在免疫介导坏死性肌病和血清阴性亚组中,肌肉损伤严重度与功能残疾呈中至强相关,其他亚组相关性较低。
  • 这些发现提示自身抗体可能是有用的长期损伤预测因子。

研究设计与样本

  • 基于MYONET注册库的纵向多中心研究,纳入接受自身抗体检测且至少有一次Myositis Damage Index(MDI)评估的患者。
  • 按自身抗体谱分为肌炎特异性、肌炎相关性或血清阴性亚组。
  • 以首次登记MDI评估时间点为索引日期,采用线性混合模型分析以自身抗体状态为主要预测因子的损伤纵向轨迹。
  • 共纳入757例成人特发性炎症性肌病患者。

主要发现

  • 血清阴性组(参照组)自诊断后每病程年估计MDI评分增加0.16单位。
  • 与血清阴性组相比,皮肌炎特异性自身抗体患者自诊断后每随访年损伤评分平均少增加0.08分(P=0.04)。
  • 与血清阴性组相比,抗PM/Scl自身抗体患者自诊断后每随访年损伤评分平均多增加0.28分(P=0.03),独立于性别和诊断时年龄。
  • 随访五年时,血清阴性亚组肌肉损伤严重度与HAQ-DI评分相关性最强,rho=0.84,P<0.001。
  • 随访五年时,免疫介导坏死性肌病自身抗体亚组肌肉损伤严重度与HAQ-DI评分相关性为rho=0.72,P<0.001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the trajectories of changes in damage over time and explore associations with autoantibody defined subgroups using a large international cohort of patients with idiopathic inflammatory myopathies (IIM). METHODS: Data from the MYONET registry, including patients who were tested for autoantibodies and had at least one assessment of damage using the Myositis Damage Index (MDI), were analyzed. Patients were sub-grouped according to their autoantibody profiles (myositis-specific, myositis-associated, or seronegative). The index date was defined as the time point for the first registered MDI assessment. The longitudinal trajectories of damage with autoantibody status as the main predictor were analyzed using linear mixed models. RESULTS: A total of 757 adult patients were included in this study. Each year of disease duration since diagnosis had an estimated MDI score increase of 0.16 units for the seronegative group (reference). Compared with the seronegative group as reference, patients with dermatomyositis-specific autoantibodies developed less damage per year of follow-up since diagnosis (average 0.08 less score, P = 0.04), whereas patients with anti-PM/Scl autoantibodies developed more damage per year of follow-up since diagnosis (average 0.28 higher score, P = 0.03) independent of sex and age at diagnosis. The seronegative subgroup and the immune-mediated necrotizing myopathy autoantibody subgroup had the strongest correlation between severity of muscle damage and HAQ-DI scores at five years of follow-up, rho=0.84, P < 0.001 and rho=0.72, P < 0.001, respectively. CONCLUSION: Our study is the first to describe patterns and trajectories of change in damage over time in relation to autoantibody defined subgroups in a large international multicenter cohort of patients with IIM. Patients with anti-PM/Scl scored a greater extent of damage, whereas patients with dermatomyositis-specific antibodies had less damage than seronegative patients. Severity in muscle damage had moderate to strong correlation with functional disability among the IMNM and seronegative subgroups with lower correlations for the other subgroups. These findings suggest that autoantibodies may be useful predictors of long-term damage.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Espinosa-Ortega F, Lodin K, Dastmalchi M, et al. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network. Semin Arthritis Rheum. 2024. PMID: 39178739. doi:10.1016/j.semarthrit.2024.152529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。